The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

India’s drug price regulator has capped retail prices for 53 drug formulations used in treating various diseases and ...

Generic medicines were sold at a discount of 20% to 90% and other medicines were sold at 25% discount. For example, metformin tablets provided to diabetic patients were sold at ₹70 by private ...

Intensive management of diabetes pays fewer dividends as patients age and raises the chances of hypoglycemia. But many people ...

Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.

Alkem Laboratories launches generic empagliflozin in India as Empanorm, offering affordable treatment for diabetes and ...

Several domestic drug makers, including Mankind Pharma, have launched the diabetes drug Empagliflozin at significantly ...

G lucagon-like peptide-1 receptor agonists, aka GLP-1 agonists, such as semaglutide -- better known as Ozempic -- have ...

Generic versions of diabetes drug Empagliflozin launched in India, crashing prices by 80-90% on day one post-patent expiry.

The price of commonly used diabetes drug empagliflozin has been slashed by almost one-tenth, with the entry of its generic ...